Premium Modified GRF (1-29) 5mg (CJC-1295 Without DAC)

Product Overview

Discover detailed product information about Premium Modified GRF (1-29) 5mg, a synthetic peptide commonly identified by the alternative name CJC-1295 without DAC. This research compound belongs to the growth hormone-releasing hormone (GHRH) analogue category and is recognized in peptide research literature for its specific molecular modifications.

For researchers exploring peptide structures, GHRH analogues, and synthetic peptide compounds, understanding the differences between Modified GRF (1-29) and related compounds is essential.

The 5mg presentation provides a clearly identified quantity for laboratory inventory management and research documentation. Whether reviewing peptide reference materials or comparing different GHRH-related compounds, accurate product identification and transparent specifications should always be priorities.

What Is Modified GRF (1-29)?

Modified GRF (1-29) is a synthetic analogue derived from the first 29 amino acids of growth hormone-releasing hormone. It incorporates structural modifications designed to improve resistance to enzymatic degradation compared with the corresponding unmodified peptide sequence.

It is commonly referred to as CJC-1295 without DAC. The distinction is important because Modified GRF (1-29) does not contain the Drug Affinity Complex (DAC) modification associated with the longer-acting CJC-1295 formulation.

Researchers should not assume that these similarly named compounds have identical structures, pharmacokinetic properties, or research characteristics.

Modified GRF (1-29) 5mg: Product Identification

When evaluating a synthetic peptide, product identification and documentation are important considerations.

Key product details include:

• Product name: Modified GRF (1-29)
• Alternative name: CJC-1295 without DAC
• Listed quantity: 5mg
• Compound category: Synthetic GHRH analogue
• Research classification: Investigational peptide
• Intended context: Laboratory research, subject to applicable regulations

Researchers should consult the supplier’s current product documentation for additional information, including molecular identity, purity testing, analytical results, and batch-specific specifications.

Modified GRF (1-29) vs. CJC-1295 With DAC

One frequently encountered source of confusion in peptide research is the difference between Modified GRF (1-29) and CJC-1295 with DAC.

Although the names are sometimes used interchangeably in informal discussions, they refer to different formulations.

Modified GRF (1-29), commonly called CJC-1295 without DAC, does not contain the additional Drug Affinity Complex modification. CJC-1295 with DAC includes an additional modification that changes its binding characteristics and pharmacokinetic profile.

Understanding this distinction is important when reviewing scientific publications, comparing research materials, and maintaining accurate laboratory records.

Quality and Documentation Considerations

Choosing research materials requires careful attention to documentation and supplier transparency.

Before purchasing any investigational peptide, researchers should consider reviewing:

• Batch-specific certificates of analysis (COAs).
• Independent analytical testing documentation.
• HPLC purity results, where available.
• Mass spectrometry identification results.
• Batch numbers and product traceability.
• Storage and handling documentation.
• Clear product identification and labeling.

A professional research supplier should make relevant product specifications and supporting documentation available for evaluation.

Importantly, a stated purity percentage or product specification should be supported by appropriate analytical evidence rather than assumed.

Where to Buy Modified GRF (1-29) 5mg?

If you are researching Modified GRF (1-29) 5mg or comparing suppliers, visit pure-peptidesuk.com to review its available product information and published specifications.

Before making a purchasing decision, independently evaluate the supplier’s business credentials, product documentation, analytical testing, shipping policies, and compliance with applicable US federal and state regulations.

US-based researchers should also verify importation requirements and any restrictions applicable to investigational peptide materials.

Important Research Notice

Modified GRF (1-29) is an investigational peptide and is not an FDA-approved medicine. This product description is intended for informational and research-identification purposes only.

It should not be interpreted as medical advice, a recommendation for human consumption, or a claim that the compound is safe or effective for treating any medical condition.

Make informed research decisions: accurate compound identification, reliable documentation, and transparent supplier information are essential when evaluating synthetic peptide materials.

Final Product Summary

Premium Modified GRF (1-29) 5mg, also known as CJC-1295 without DAC, is a synthetic GHRH analogue identified by its specific 29-amino-acid sequence and structural modifications.

For researchers comparing GHRH-related compounds, understanding its distinction from DAC-containing CJC-1295 formulations is particularly important.

Review the product specifications, analytical documentation, and applicable purchasing requirements at pure-peptidesuk.com before making any supplier decision.